Amir Amanullah
Hospital ResidentCards
About
Research
Publications
2026
Quantification of Costal Cartilage Calcification Using 18F-NaF-PET/CT
Shehu V, Gandhi O, Glennan P, Gujral J, Singh S, Amanullah A, Patil S, Gujral K, Raynor W, Park P, Teichner E, Subtirelu R, Khan T, Werner T, Høilund-Carlsen P, Gholamrezanezhad A, Revheim M, Alavi A. Quantification of Costal Cartilage Calcification Using 18F-NaF-PET/CT. Journal Of Imaging 2026, 12: 206. PMID: 42188243, PMCID: PMC13208709, DOI: 10.3390/jimaging12050206.Peer-Reviewed Original ResearchF-NaF uptakeCoronary artery calciumCoronary artery calcium scoreF-NaF PET/CTF-NaFCostal cartilage calcificationAge-related changesCardiovascular Molecular CalcificationReceiver operating characteristic analysisEffects of ageCoronary artery calcificationOperating characteristic analysisOsseous uptakeCT attenuationArtery calciumRetrospective studyCartilage calcificationArtery calcificationClinical trialsMolecular calcificationLeft sideCalcificationCharacteristic analysisCostal cartilageImaging parametersThe emerging role of ¹⁸F-NaF PET/CT in osteoporosis: an emphasis on its application for the evaluation and management of lumbar spine osteoporosis
Gujral J, Gandhi O, Amanullah A, Dagli M, Singh S, Ayubcha C, Werner T, Revheim M, Welch W, Alavi A. The emerging role of ¹⁸F-NaF PET/CT in osteoporosis: an emphasis on its application for the evaluation and management of lumbar spine osteoporosis. EJNMMI Research 2026, 16: 93. PMID: 42053848, PMCID: PMC13269627, DOI: 10.1186/s13550-026-01411-1.Peer-Reviewed Original ResearchDual-energy X-ray absorptiometryDual-energy X-ray absorptiometry findingsClinical applicationBone mineral density assessmentConclusion18F-NaF PET/CTLumbar spine osteoporosisBone turnover markersHigh-risk patientsX-ray absorptiometryBone mineral densityMineral density measurementsMetabolic bone disordersEvaluation of patientsReceiver operating characteristic curveOptimal clinical applicationTreatment response monitoringDiagnostic performance studyNarrative reviewPre-surgical assessmentOperating characteristics curvePersonalized treatment plansTrabecular boneBone metabolic activitySpine osteoporosisComprehensive narrative reviewCharacterization of regional brain metabolic changes in metastatic melanoma using 18F-FDG PET/CT imaging: A case report.
Gandhi O, Gujral J, Amanullah A, Patil S, Subtirelu R, Teichner E, Mhana S, Werner T, Alavi A, Revheim M. Characterization of regional brain metabolic changes in metastatic melanoma using 18F-FDG PET/CT imaging: A case report. Hellenic Journal Of Nuclear Medicine 2026, 29: 34-38. PMID: 42001440, DOI: 10.1967/s002449912944.Peer-Reviewed Original ResearchConceptsRegional brain metabolic changesBrain metabolic changesMagnetic resonance imagingBrain metastasesMetastatic melanomaF-FDGMelanoma patientsCase reportF-FDG PET/CTMetabolic changesFluorine-18 fluorodeoxyglucoseImmune-mediated pathwaysMIMneuro softwarePET/CT restagingLeft occipital areasPET/CT imagingDisease assessmentInfiltrative lesionsFunctional brain alterationsImaging findingsPoor prognosisClinical challengeMetabolic disturbancesMetastasisNeurological defectsSomatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance
Gujral J, Gandhi O, Amanullah A, Singh S, Ayubcha C, Patil S, Werner T, Revheim M, Brem S, Alavi A. Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance. Nuclear Medicine Communications 2026, 47: 491-502. PMID: 41693498, PMCID: PMC13015810, DOI: 10.1097/mnm.0000000000002122.Peer-Reviewed Original ResearchConceptsSomatostatin receptor 2Central nervous systemSSTR-PETStandardized uptake value thresholdPrimary central nervous systemSomatostatin receptor PETProspective multicenter trialTumor-to-background contrastReview of PubMedLiterature review of PubMedTargeted radionuclide therapyComputed tomography imagesTheranostic paradigmSimpson gradeResidual tumorDisease stabilizationRadiation planningDural enhancementTarget volumePosttreatment surveillanceOccult diseaseMulticenter trialMeningioma patientsRadionuclide therapyMeningioma managementRole of FDG-PET/CT in detecting metabolic changes in parotid glands following photon versus proton therapy.
Gandhi O, Gujral J, Amanullah A, Ismoilov M, Singh S, Patil S, Ahmed M, Niazi S, Motamedi N, Shrestha B, Werner T, Revheim M, Alavi A. Role of FDG-PET/CT in detecting metabolic changes in parotid glands following photon versus proton therapy. American Journal Of Nuclear Medicine And Molecular Imaging 2026, 16: 114-124. PMID: 42183160, PMCID: PMC13191560, DOI: 10.62347/pesp7804.Peer-Reviewed Original ResearchHead and neck cancerF-FDG PET/CTDisabling side effectsParotid glandProton therapyRadiation therapyPhoton therapyMetabolic changesHead and neck cancer patientsBilateral parotid glandsStandardized uptake valueF-FDG uptakeParotid gland injuryMetabolic evidenceTissue-sparing effectMonths post-treatmentConcurrent chemotherapyDosimetric advantagesFDG-PET/CTPhoton RTF-FDGGland injuryUptake valueNeck cancerRetrospective study
2025
An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review
Sahni V, Yim R, Amanullah A, Sahni D, Powell D, deShazo R, Rhoads J, Clarke J, Hansen C, Zone J, Hull C, Hopkins Z. An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review. Dermatitis 2025, 37: 13-19. PMID: 40971250, DOI: 10.1177/17103568251378523.Peer-Reviewed Original ResearchConceptsAllergen avoidancePatch testingPositive patch testsExposure to allergensPatient-reported outcomesOrofacial granulomatosisGranulomatous cheilitisControlled studiesDegree of improvementPatientsContact allergyMultimodal approachNarrative reviewAllergensPositive resultsCurrent literatureAllergyAllergy avoidanceTrialsDietCheilitisGranulomatosisSyndromeReviewThe Genetics of Amyloid Deposition: A Systematic Review of Genome-Wide Association Studies Using Amyloid PET Imaging in Alzheimer’s Disease
Amanullah A, Mirbod M, Pandey A, Singh S, Gandhi O, Ayubcha C. The Genetics of Amyloid Deposition: A Systematic Review of Genome-Wide Association Studies Using Amyloid PET Imaging in Alzheimer’s Disease. Journal Of Imaging 2025, 11: 280. PMID: 40863490, PMCID: PMC12387344, DOI: 10.3390/jimaging11080280.Peer-Reviewed Original ResearchGenome-wide association studiesAssociation studiesAlzheimer's diseaseVariants associated with disease riskGenetic variants associated with disease riskContext of genome-wide association studiesGenetic determinantsSystematic review of genome-wide association studiesPrecision medicine effortsGenetic architectureGenetic lociSystematic reviewGenetic mechanismsMitochondrial functionAD pathologyBiological pathwaysCell adhesionImmune responseLipid metabolismRisk of biasLociAmyloid depositsSynaptic regulationMedicine effortsAmyloid burdenConsiderations and Indications for Gastric Emptying Scintigraphy in Lung Transplant Patients
Sisti J, Bolet S, Amanullah A, Malik Z, Parkman H, Maurer A, Cheng K, Dadparvar S. Considerations and Indications for Gastric Emptying Scintigraphy in Lung Transplant Patients. Asia Oceania Journal Of Nuclear Medicine And Biology 2025, 13: 53-61. PMID: 39744049, PMCID: PMC11682477, DOI: 10.22038/aojnmb.2024.80821.1572.Peer-Reviewed Original ResearchGastric emptying scintigraphyLung transplant recipientsLung-transplant recipientsTransplant recipientsDelayed gastric emptyingLung transplantationGastric emptyingRisk of delayed gastric emptyingGastric emptying scintigraphy resultsIncidence of delayed gastric emptyingBilateral lung transplant recipientsDelayed gastric emptying rateEvaluation of gastrointestinal symptomsTechnetium-99m sulfur colloidOne-year post-transplantLung transplant patientsProportion of patientsPrevalence of gastroparesisGastric emptying rateSevere gastroparesisTransplant patientsNo significant differencePost-transplantRetrospective analysisGastrointestinal symptomsSomatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review.
Gujral J, Gandhi O, Amanullah A, Singh S, Ayubcha C, Werner T, Revheim M, Alavi A. Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review. American Journal Of Nuclear Medicine And Molecular Imaging 2025, 15: 223-235. PMID: 41567833, PMCID: PMC12816823, DOI: 10.62347/lyat6783.Peer-Reviewed Original ResearchWorld Health OrganizationRisk of tumor recurrenceWorld Health Organization tumor gradePET-guided treatmentWorld Health Organization gradeCancer treatment paradigmPrimary intracranial tumorsPatient selection strategiesHigher World Health OrganizationQuantitative imaging featuresSSTR2 overexpressionGrade tumorsRadiation therapyIII meningiomasTumor recurrenceClinical responseTumor gradeSomatostatin analogsSUV parametersProgressive diseaseIntracranial tumorsMeningioma patientsMulticenter studyTherapeutic optionsTreatment paradigm
2024
Risk Factors for Progression of Cervical Congenital Scoliosis and Associated Compensatory Curve Behavior
Amanullah A, Oh T, Toll B, Patel A, Samdani A, Pahys J, Kim A, Vellanki A, Steindler J, Ishmael T, Hwang S. Risk Factors for Progression of Cervical Congenital Scoliosis and Associated Compensatory Curve Behavior. Journal Of Clinical Medicine 2024, 13: 3039. PMID: 38892749, PMCID: PMC11172909, DOI: 10.3390/jcm13113039.Peer-Reviewed Original ResearchCongenital cervical scoliosisT1 slopeCoronal curveConclusion:Follow-upCervical spine deformityCurve magnitudeRisk factorsLumbar curve magnitudeCentral sacral vertical lineCervical curveCoronal curve angleCervical deformityCervical scoliosisInclusion criteriaLumbar spineSpine deformityProgression of deformityLumbar curveMedical recordsCongenital scoliosisCurve sizeCompensatory curveC7-CSVLPediatric patients